Details for 2013169139

Up to date per 28.04.2026

Actions

Title / Product Name

Zusammensetzungen und deren Verwendung zur Behandlung von Multipler Sklerose

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2013169139

EP Publication Number

2653873

E-Number

1505849

Language

PCT Number

Publication Date

23.10.2013 A

20.07.2022 B1

Registration Date

20.07.2022

AT Publication Date

15.08.2022

Application Date

07.02.2008

Registration Number

Priorities

08.02.2007

888921 P

IPC

G01N 33/68 20060101AFI20130913BHEP

Maximum Duration of Protection

07.02.2028

Owner

Biogen MA Inc.225 Binney Street Cambridge, MA 02142US

Representative

Dipl.-Ing. Werner Barger, Dipl.-Ing. Dr.techn. Peter IsrailoffOperngasse 41010 WienAT

Inventor

Lukashev, Matvey, E.3 Louis Road Tewksbury, MA 01876US

O'Neill, Gilmore17 Grove Street Medford, MA 02155US

Information about Fees